341P Cost-effectiveness analysis of first-line atezolizumab for patients with stage IV non-small cell lung cancer whose tumours have a high-programmed death ligand 1 expression in Thailand

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 33; pp. S1575 - S1576
Main Authors	Kittrongsiri, K., Abogunrin, S., Celik, H., Sangroongruangsri, S.
Format	Journal Article
Language	English
Published	01.11.2022
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2022.10.379